Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.

British journal of clinical pharmacology2006Backman JT, Karjalainen MJ, Neuvonen M, et al.

Study designRandomized controlled trial

SubjectHuman

Record checks

Study design: Randomized controlled trial
Subject: Human
Publication year: 2006
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AdultCaffeineCentral Nervous System StimulantsClonidineCyclooxygenase 2 InhibitorsCytochrome P-450 CYP1A2 InhibitorsDouble-Blind MethodDrug InteractionsHumansLactonesMaleSulfones

DOI 10.1111/j.1365-2125.2006.02653.x

PMID 16934051

View source →